0.61
0.01 (1.67%)
0.01 (1.67%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InVivo Therapeutics Holdings Corporation | NVIV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.01 | 1.67% | 0.61 | 00:00:05 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 0.5895 | 0.57 | 0.62 | 0.62 | 0.60 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.59 | 0.695 | 0.105 | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,083 | 3,991,742 | $ 0.5995074 | $ 2,393,079 | 684,629 | 0.119 - 8.5074 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:23 | formt | 800 | $ 0.61 | USD |
InVivo Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.98M | 4.88M | 4.61M | $ - | $ - | -35.30 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
InVivo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVIV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.36 | 1.40 | 0.566 | 0.6388501 | 3,776,702 | -0.75 | -55.15% |
| 1 Month | 1.30 | 1.50 | 0.566 | 0.6872192 | 960,358 | -0.69 | -53.08% |
| 3 Months | 1.65 | 1.7494 | 0.566 | 0.8401591 | 412,709 | -1.04 | -63.03% |
| 6 Months | 1.37 | 2.70 | 0.566 | 1.28 | 441,550 | -0.76 | -55.47% |
| 1 Year | 0.42 | 8.5074 | 0.119 | 0.9020948 | 656,853 | 0.19 | 45.24% |
| 3 Years | 37.50 | 37.50 | 0.119 | 4.53 | 356,298 | -36.89 | -98.37% |
| 5 Years | 190.50 | 295.00 | 0.119 | 44.65 | 324,251 | -189.89 | -99.68% |
InVivo Therapeutics Description
| InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury. |
